Concepedia

Matthew Clemens

MC

Statistics

Publications

5

Citations

306

H-Index

5

Active since

1995

Affiliations

Eli Lilly (United States)(Current)

Matthew Clemens is an author at Eli Lilly (United States) specializing in pharmacy, medicinal chemistry, and drug discovery.

Publications per year

1995–2019

5

Publications

5

Novel Lipoglycopeptides as Inhibitors of Bacterial Signal Peptidase I

Palaniappan Kulanthaivel, A J Kreuzman, Mark A. Strege et al. · Journal of Biological Chemistry · 2004 · 102 citations · Full text

, , +17

The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase

C. Åhgren, K Backro, F. WILLIAM BELL et al. · Antimicrobial Agents and Chemotherapy · 1995 · 94 citations

, , +17

Solution Stability of Poloxamer 188 Under Stress Conditions

Tingting Wang, Aaron P. Markham, Steven J. Thomas et al. · Journal of Pharmaceutical Sciences · 2018 · 53 citations

, , +8

Genetic variability and mRNA editing frequencies of the phosphoprotein genes of wild-type measles viruses

Bettina Bankamp, Elena N. Lopareva, Jacques R. Kremer et al. · Virus Research · 2008 · 44 citations · Full text

, , +16

The Degradation Chemistry of Prasugrel Hydrochloride: Part 1—Drug Substance

Steven W. Baertschi, Lindsay Maxwell-Backer, Matthew Clemens et al. · Journal of Pharmaceutical Sciences · 2019 · 13 citations

, , +16

1–5 of 5